Completion of enrollment earlier this year and expected final PanCAN grant payment this quarter mark successful completion of a key phase of ...

AN4035, a first-in-class investigational pan-RAS(ON) inhibitor-based ADC, will be evaluated as monotherapy and in combination with cetuximab in ...

VERAXA Biotech (VRXA) presented its first animal proof-of-concept results for BiTAC-ADC cancer therapy technology at the World ADC Congress. A single 3 mg/kg dose produced tumor regression in a breast ...

The Nasdaq 52-week range stood at USD 2.38 to USD 29.98 on October 15, 2026. Seres Therapeutics stock costs EUR 2.28 on ...

A massive wave of job cuts is looming in the German chemical industry. Three weeks ago, Evonik CEO Claus Rettig asserted he ...

The list of departing ASX biotech CEOs continues to swell, with Medical Developments chief Brent MacGregor signing off today.

Stocks like HCL Technologies, YES Bank, Wipro, Jio Financial, Mankind Pharma, Premier Energies, Angel One, Sri Lotus and more ...

ASML shares rose as much as 3.6% in Amsterdam, lifting the European sector index by more than 1%. The stock has gained almost ...

The U.S. dollar retreated from an 18-month high, while gold dipped below $4,150 an ounce, extending losses for the third straight session ahead of U.S. CPI data later in the day, which could influence ...

Oncolytics Biotech® Inc. has announced the successful completion of enrollment in its GOBLET Phase 1/2 study, alongside the ...

Today's Impressions and HighlightsThe Philadelphia Semiconductor Index (SOX) fell for the fourth consecutive day. Memory ...

Amgen stock is at EUR 386.78 pre-market, according to Lang & Schwarz. The quote was recorded at 8:04 a.m. CEST on October 16, ...